Red Cell Partners Appoints Michael Kilberry as Chief Product and Technology Officer

Red Cell Partners has appointed Michael Kilberry as its new chief product and technology officer. Kilberry brings extensive experience in the finance industry, previously working at Bloomberg. His appointment is expected to strengthen Red Cell's product and technology capabilities.

Red Cell Partners, a prominent incubation and investment firm specializing in rapidly scalable technology-led companies, has appointed Michael Kilberry as its new Chief Product and Technology Officer. Kilberry, a seasoned executive with extensive experience in the technology sector, brings a wealth of expertise that is expected to significantly bolster Red Cell's product and technology capabilities.

Kilberry, who previously held senior roles at Google and Amazon, will be responsible for shaping and executing the product and technology vision across Red Cell's ecosystem. He will identify market opportunities, define product and technical strategies, and work closely with teams across Red Cell’s incubations to guide the development and delivery of innovative, mission-driven technologies. Kilberry's appointment follows his successful tenure at Google Cloud, where he served as Head of Product for AI/ML, Data & Analytics. Before joining Google, he founded and led an applied AI startup in the legal industry and held senior leadership roles at Microsoft and Snowflake [1].

Red Cell Partners, which focuses on healthcare, cyber, and national security, aims to develop powerful tools and technologies to address pressing national challenges. With Kilberry's leadership, the company hopes to accelerate its product development and technology initiatives, positioning itself to respond effectively to the rapidly evolving market demands. Kilberry's appointment underscores Red Cell's commitment to leveraging cutting-edge technology to drive innovation and improve patient outcomes [2].

References:
[1] https://finance.yahoo.com/news/michael-kilberry-former-google-amazon-120000390.html
[2] https://www.terumo.com/newsrelease/detail/20250711/6656